Acute Myelogenous Leukemia: Clinical Trials

2 trials for Acute Myelogenous Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Acute Myelogenous Leukemia: new trials by email Literature Review of Acute Myelogenous Leukemia trials Research Report on Acute Myelogenous Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
micafungin, posaconazole - Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Phase 4CompletedMemorial Sloan Kettering Cancer Center1132010-09-092018-05-07
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
Posaconazole - Fungal Infection, Acute Myelogenous Leukemia
Phase 4CompletedMerck Sharp & Dohme LLC752007-12-012017-04-07

Narrower conditions

Leukemia, Myeloid, Acute (2)  ·  Mycoses (1)  ·  Myelodysplastic Syndromes (1)  ·  Neutropenia (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Agranulocytosis (1)  ·  Bacterial Infections and Mycoses (1)  ·  Bone Marrow Diseases (1)  ·  Cytopenia (1)  ·  Infections (1)  ·  Leukocyte Disorders (1)  ·  Leukopenia (1)

Interventions

posaconazole (2)  ·  Micafungin (1)

Sponsors

Memorial Sloan Kettering Cancer Center (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (1)

Top investigators

Genovefa Papanicolaou, MD (1)

Results publications

PMID 22290953